While the majority of current research has concentrated on tissue and cellular expression, recent evidence also indicates elevated levels of NR2F1-AS1 in the serum of hepatocellular carcinoma (HCC) patients [38]. Here, NR2F1 is linked to hepatocellular carcinoma.